Login to Your Account



Eyetech's Strong IPO Performance Provides Momentum To Filed Bids

By Randall Osborne


Monday, February 9, 2004

Any pupil of biotech will tell you: One eyebrow-raising initial public offering does not an IPO wave make. Still, observers held hopes that if Eyetech Pharmaceuticals Inc. came through with a solid pricing and decent after-market performance, more of the pending IPOs might follow suit.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription